Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C.

被引：0
|
作者：
Kasahara, A
Hayashi, N
Sasaki, Y
Kakumu, S
Kiyosawa, K
Okita, K
机构：
[1] Osaka Univ, Suita, Osaka, Japan
[2] Aichi Med Coll, Nagoya, Aichi, Japan
[3] Shinshu Univ, Matsumoto, Nagano 390, Japan
[4] Yamaguchi Univ, Ube, Yamaguchi 755, Japan
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
807
引用
收藏
页码：361A / 361A
页数：1
相关论文
共 50 条
  • [41] Low Incidence of Hepatocellular Carcinoma after Antiviral Therapy in Patients with Chronic Hepatitis C and Hemophilia
    Kim, In Jung
    Yoo, Sung Hwan
    Kim, Sora
    Cho, Young Youn
    Yoo, Ki Young
    Kim, Hyung Joon
    Lee, Hyun Woong
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [42] Liver stiffness and the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Nakayama, Yuji
    Takeda, Tadashi
    Yasuda, Takahiro
    Nakaya, Mika
    Nakahara, Kenishi
    Fujii, Hideki
    Kobayashi, Sawako
    Iwai, Shuuji
    Enomoto, Masaru
    Tamori, Akihiro
    Sakaguchi, Hiroki
    Habu, Daiki
    Seki, Shuichi
    Kawada, Nonfumi
    GASTROENTEROLOGY, 2007, 132 (04) : A780 - A780
  • [43] Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients
    Ishikawa, Toru
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (40) : 6140 - 6144
  • [44] Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients
    Toru Ishikawa
    World Journal of Gastroenterology, 2008, (40) : 6140 - 6144
  • [45] Long term effect of interferon therapy in children with chronic hepatitis C.
    Sawada, A
    Tajiri, H
    Tada, K
    Etani, Y
    Ozaki, Y
    Kozaiwa, K
    Okada, S
    Sako, M
    Kanesaki, T
    GASTROENTEROLOGY, 1996, 110 (04) : A1313 - A1313
  • [46] Induction therapy with consensus interferon in the treatment of patients with chronic hepatitis C.
    Kwo, PY
    Fields, S
    Chalasani, N
    Cho, W
    Crabb, DW
    Cummings, OW
    Imperiale, TF
    Lumeng, L
    McGill, JM
    Ness, RM
    Pintozzi, R
    Jones, B
    Lansford, C
    Maier, J
    Isenberg, M
    Mark, D
    Bennet, C
    Noar, M
    McCone, J
    Chasen, R
    Geissinger, B
    Goldstein, M
    Thuluvath, P
    GASTROENTEROLOGY, 2000, 118 (04) : A1460 - A1460
  • [47] Estimating the benefit of interferon therapy for individual patients with chronic hepatitis C.
    Yoshida, H
    Tateishi, R
    Arakawa, Y
    Sata, M
    Nishiguchi, S
    Ishibashi, H
    Fujiyama, S
    Yamada, G
    Yokosuka, O
    Shiratori, Y
    Omata, M
    HEPATOLOGY, 2003, 38 (04) : 641A - 641A
  • [48] Interferon Therapy and Prevention of Hepatocellular Carcinoma in Hepatitis C
    Amit G. Singal
    Jorge A. Marrero
    Digestive Diseases and Sciences, 2012, 57 : 832 - 834
  • [49] Interferon Therapy and Prevention of Hepatocellular Carcinoma in Hepatitis C
    Singal, Amit G.
    Marrero, Jorge A.
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (04) : 832 - 834
  • [50] Does interferon therapy prevent hepatocellular carcinoma in patients with chronic viral hepatitis?
    Vezali, Elena
    Aghemo, Alessio
    Lampertico, Pietro
    Colombo, Massimo
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 (6-7) : 455 - 464
12345